| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Rowland Stephen Eric | President | C/O KLAVIYO, INC., 125 SUMMER STREET, 6TH FLOOR, BOSTON | /s/ Landon Edmond, Attorney-in-Fact | 2025-05-16 | 0001639368 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KVYO | Series A Common Stock | Sale | -$230K | -6.56K | -1.47% | $35.06 | 441K | May 15, 2025 | Direct | F1, F2 |
| transaction | KVYO | Series A Common Stock | Sale | -$17.1K | -500 | -0.11% | $34.19 | 440K | May 15, 2025 | Direct | F1, F3 |
| transaction | KVYO | Series A Common Stock | Conversion of derivative security | +23K | +5.21% | 463K | May 15, 2025 | Direct | F4, F5 | ||
| transaction | KVYO | Series A Common Stock | Tax liability | -$1.2M | -34.5K | -7.44% | $34.90 | 429K | May 15, 2025 | Direct | F6 |
| transaction | KVYO | Series A Common Stock | Conversion of derivative security | +28.4K | +6.61% | 457K | May 15, 2025 | Direct | F5 | ||
| transaction | KVYO | Series A Common Stock | Sale | -$247K | -7.08K | -1.55% | $34.86 | 450K | May 16, 2025 | Direct | F1, F7, F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KVYO | Series B Common Stock | Conversion of derivative security | $0 | -23K | -4.47% | $0.00 | 490K | May 15, 2025 | Series A Common Stock | 23K | Direct | F4, F5 | |
| transaction | KVYO | Series B Common Stock | Conversion of derivative security | $0 | -28.4K | -5.78% | $0.00 | 462K | May 15, 2025 | Series A Common Stock | 28.4K | Direct | F5, F9 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2024 |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.65 to $35.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.89 to $34.47 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | Represents 22,957 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). |
| F5 | Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| F6 | Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. |
| F7 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.50 to $35.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | Consists of (i) 114,700 shares of Series A Common Stock and (ii) 335,303 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. |
| F9 | Consists of 461,808 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. |